Arcus Biosciences, Inc. RCUS
i
Market dataready · fetched 2026-11-12T01:52:06.398Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:00:00.002246359Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-12T01:52:06.056990+00:00
Arcus Biosciences, Inc. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 15.05 | 207.7% | 24.1% | |||
| 25Δ | 15.53 | 193.7% | 21.9% | |||
| 30Δ | 16.00 | 179.7% | 19.8% | |||
| 35Δ | 37.09 | 540.9% | 110.6% | 16.48 | 165.7% | 17.6% |
| 40Δ | 32.52 | 468.8% | 86.3% | 16.95 | 151.7% | 15.4% |
| 45Δ | 29.64 | 409.7% | 71.0% | 17.43 | 137.7% | 13.2% |
| 50Δ | 26.76 | 350.5% | 55.7% | 17.90 | 123.7% | 11.1% |
| 55Δ | 23.88 | 291.3% | 40.5% | 18.38 | 109.7% | 8.9% |
| 60Δ | 21.00 | 232.1% | 25.2% | 18.85 | 95.7% | 6.7% |
| 65Δ | 18.12 | 173.0% | 9.9% | 19.33 | 81.7% | 4.5% |
| 70Δ | 16.27 | 181.8% | 5.9% | 19.80 | 67.7% | 2.4% |
| 75Δ | 14.69 | 209.1% | 4.9% | 20.36 | 63.8% | 1.3% |
| 80Δ | 13.12 | 236.5% | 4.0% | 20.97 | 67.2% | 1.0% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 15.05
- IV
- 207.7%
- B/E move
- 24.1%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 15.53
- IV
- 193.7%
- B/E move
- 21.9%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 16.00
- IV
- 179.7%
- B/E move
- 19.8%
35Δ
- Pseudo strike
- 37.09
- IV
- 540.9%
- B/E move
- 110.6%
- Pseudo strike
- 16.48
- IV
- 165.7%
- B/E move
- 17.6%
40Δ
- Pseudo strike
- 32.52
- IV
- 468.8%
- B/E move
- 86.3%
- Pseudo strike
- 16.95
- IV
- 151.7%
- B/E move
- 15.4%
45Δ
- Pseudo strike
- 29.64
- IV
- 409.7%
- B/E move
- 71.0%
- Pseudo strike
- 17.43
- IV
- 137.7%
- B/E move
- 13.2%
50Δ
- Pseudo strike
- 26.76
- IV
- 350.5%
- B/E move
- 55.7%
- Pseudo strike
- 17.90
- IV
- 123.7%
- B/E move
- 11.1%
55Δ
- Pseudo strike
- 23.88
- IV
- 291.3%
- B/E move
- 40.5%
- Pseudo strike
- 18.38
- IV
- 109.7%
- B/E move
- 8.9%
60Δ
- Pseudo strike
- 21.00
- IV
- 232.1%
- B/E move
- 25.2%
- Pseudo strike
- 18.85
- IV
- 95.7%
- B/E move
- 6.7%
65Δ
- Pseudo strike
- 18.12
- IV
- 173.0%
- B/E move
- 9.9%
- Pseudo strike
- 19.33
- IV
- 81.7%
- B/E move
- 4.5%
70Δ
- Pseudo strike
- 16.27
- IV
- 181.8%
- B/E move
- 5.9%
- Pseudo strike
- 19.80
- IV
- 67.7%
- B/E move
- 2.4%
75Δ
- Pseudo strike
- 14.69
- IV
- 209.1%
- B/E move
- 4.9%
- Pseudo strike
- 20.36
- IV
- 63.8%
- B/E move
- 1.3%
80Δ
- Pseudo strike
- 13.12
- IV
- 236.5%
- B/E move
- 4.0%
- Pseudo strike
- 20.97
- IV
- 67.2%
- B/E move
- 1.0%
Options history
Table
| Date | IV (%) |
|---|---|
| 85.04% | |
| 65.43% | |
| 77.01% | |
| 77.10% | |
| 87.13% | |
| 80.65% | |
| 74.82% |
Biotechnology
REGN
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their…
More →REPL
Replimune Group, Inc., a biotechnology company, develops oncolytic immunogenic therapies to treat cancer. The company is headquartered in Woburn, Massachusetts.
More →RGNX
REGENXBIO Inc., a clinical-stage biotechnology company, offers candidate gene therapy products to deliver genes to cells to address genetic defects or to enable cells in the body…
More →RIGL
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat blood disorders, cancer, and rare immune diseases. The company is…
More →RLAY
Relay Therapeutics, Inc. is a clinical-stage precision drug company. The company is headquartered in Cambridge, Massachusetts.
More →RLMD
Description unavailable
More →